Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody

World Journal of Gastroenterology

Volumn 24, Issue 48, 2018, Pages 5491-5504

  Tsuji, Atsushi B ^b   Sugyo, Aya ^b   Takashima, Hiroki ^a   Yasunaga, Masahiro ^a   Matsumura, Yasuhiro ^a   Higashi, Tatsuya ^b   Aung, Winn ^b  

^a National Cancer Center   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Anti tissue factor antibody; Indocyanine green; Near infrared; Pancreatic cancer; Photoimmunotherapy

Indexed keywords

ANTINEOPLASTIC MONOCLONAL ANTIBODY; EOSIN; HEMATOXYLIN; INDOCYANINE GREEN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY 1849; THROMBOPLASTIN; UNCLASSIFIED DRUG; ANTIBODY CONJUGATE; MONOCLONAL ANTIBODY; PHOTOSENSITIZING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BXPC-3 CELL LINE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL DEATH; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIGHT EXPOSURE; MALE; MOUSE; NEAR INFRARED PHOTOIMMUNOTHERAPY; NONHUMAN; PANCREAS CANCER; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION LEVEL; STAINING; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG SCREENING; IMMUNOLOGY; IMMUNOTHERAPY; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; PANCREAS TUMOR; PHOTOTHERAPY; PROCEDURES; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; HUMANS; IMMUNOCONJUGATES; IMMUNOTHERAPY; INDOCYANINE GREEN; MICE; MICE, INBRED BALB C; MICE, NUDE; PANCREATIC NEOPLASMS; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; THROMBOPLASTIN; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85059388242     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v24.i48.5491     Document Type: Article

References (52)

1. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1459-1544 [PMID: 27733281 DOI: 10.1016/ S0140-6736(16)31012-1]
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68: 7-30 [PMID: 29313949 DOI: 10.3322/caac.21442]
3. Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol 2009; 27: 4834-4838 [PMID: 19738116 DOI: 10.1200/JCO.2009.22.6324]
4. van den Berg YW, Osanto S, Reitsma PH, Versteeg HH. The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood 2012; 119: 924-932 [PMID: 22065595 DOI: 10.1182/blood-2011-06-317685]
5. Leppert U, Eisenreich A. The role of tissue factor isoforms in cancer biology. Int J Cancer 2015; 137: 497-503 [PMID: 24806794 DOI: 10.1002/ijc.28959]
6. Kakkar AK, Lemoine NR, Scully MF, Tebbutt S, Williamson RC. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg1995; 82: 1101-1104 [PMID: 7648165 DOI: 10.1002/bjs.1800820831]
7. Ueda C, Hirohata Y, Kihara Y, Nakamura H, Abe S, Akahane K, Okamoto K, Itoh H, Otsuki M. Pancreatic cancer complicated by disseminated intravascular coagulation associated with production of tissue factor. J Gastroenterol 2001; 36: 848-850 [PMID: 11777214]
8. Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, Hostetter G, Harvey J, Taubman MB. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 2007; 13: 2870-2875 [PMID: 17504985 DOI: 10.1158/1078-0432. CCR-06-2351]
9. Hobbs JE, Zakarija A, Cundiff DL, Doll JA, Hymen E, Cornwell M, Crawford SE, Liu N, Signaevsky M, Soff GA. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb Res 2007; 120 Suppl 2: S13-S21 [PMID: 18023707 DOI: 10.1016/S0049-3848(07)70126-3]
10. Haas SL, Jesnowski R, Steiner M, Hummel F, Ringel J, Burstein C, Nizze H, Liebe S, Löhr JM. Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation. World J Gastroenterol 2006; 12: 4843-4849 [PMID: 16937466]
11. Tsumura R, Sato R, Furuya F, Koga Y, Yamamoto Y, Fujiwara Y, Yasunaga M, Matsumura Y. Feasibility study of the Fab fragment of a monoclonal antibody against tissue factor as a diagnostic tool. Int J Oncol 2015; 47: 2107-2114 [PMID: 26497165 DOI: 10.3892/ijo.2015.3210]
12. Koga Y, Manabe S, Aihara Y, Sato R, Tsumura R, Iwafuji H, Furuya F, Fuchigami H, Fujiwara Y, Hisada Y, Yamamoto Y, Yasunaga M, Matsumura Y. Antitumor effect of antitissue factor antibody-MMAE conjugate in human pancreatic tumor xenografts. Int J Cancer 2015; 137: 1457-1466 [PMID: 25704403 DOI: 10.1002/ijc.29492]
13. Takashima H, Tsuji AB, Saga T, Yasunaga M, Koga Y, Kuroda JI, Yano S, Kuratsu JI, Matsumura Y. Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model. Sci Rep 2017; 7: 12341 [PMID: 28951589 DOI: 10.1038/s41598-017-12563-5]
14. 89Zr-Df-ALT-836. J Control Release 2017; 264: 160-168 [PMID: 28843831 DOI: 10.1016/ j.jconrel.2017.08.029]
15. Hong H, Zhang Y, Nayak TR, Engle JW, Wong HC, Liu B, Barnhart TE, Cai W. Immuno-PET of tissue factor in pancreatic cancer. J Nucl Med 2012; 53: 1748-1754 [PMID: 22988057 DOI: 10.2967/ jnumed.112.105460]
16. Shi S, Hong H, Orbay H, Graves SA, Yang Y, Ohman JD, Liu B, Nickles RJ, Wong HC, Cai W. ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment. Eur J Nucl Med Mol Imaging 2015; 42: 1295-1303 [PMID: 25801992 DOI: 10.1007/s00259-015-3038-1]
17. Wang B, Berger M, Masters G, Albone E, Yang Q, Sheedy J, Kirksey Y, Grimm L, Wang B, Singleton J, Soltis D. Radiotherapy of human xenograft NSCLC tumors in nude mice with a 90Y-labeled antitissue factor antibody. Cancer Biother Radiopharm 2005; 20: 300-309 [PMID: 15989475 DOI: 10.1089/cbr.2005.20.300]
18. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182: 311-322 [PMID: 10653597 DOI: 1 0.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9]
19. Sudo H, Tsuji AB, Sugyo A, Ogawa Y, Sagara M, Saga T. ZDHHC8 knockdown enhances radiosensitivity and suppresses tumor growth in a mesothelioma mouse model. Cancer Sci 2012; 103: 203-209 [PMID: 22017350 DOI: 10.1111/j.1349-7006.2011.02126.x]
20. Kano MR, Bae Y, Iwata C, Morishita Y, Yashiro M, Oka M, Fujii T, Komuro A, Kiyono K, Kaminishi M, Hirakawa K, Ouchi Y, Nishiyama N, Kataoka K, Miyazono K. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. Proc Natl Acad Sci USA 2007; 104: 3460-3465 [PMID: 17307870 DOI: 10.1073/pnas.0611660104]
21. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011; 61: 250-281 [PMID: 21617154 DOI: 10.3322/caac.20114]
22. Shirasu N, Nam SO, Kuroki M. Tumor-targeted photodynamic therapy. Anticancer Res 2013; 33: 2823-2831 [PMID: 23780966]
23. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007; 2: 751-760 [PMID: 18654426 DOI: 10.1038/ nnano.2007.387]
24. Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med 2011; 17: 1685-1691 [PMID: 22057348 DOI: 10.1038/nm.2554]
25. Burley TA, Mączyńska J, Shah A, Szopa W, Harrington KJ, Boult JKR, Mrozek-Wilczkiewicz A, Vinci M, Bamber JC, Kaspera W, Kramer-Marek G. Near-infrared photoimmunotherapy targeting EGFR-Shedding new light on glioblastoma treatment. Int J Cancer 2018; 142: 2363-2374 [PMID: 29313975 DOI: 10.1002/ijc.31246]
26. Nakamura Y, Ohler ZW, Householder D, Nagaya T, Sato K, Okuyama S, Ogata F, Daar D, Hoa T, Choyke PL, Kobayashi H. Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer. Mol Cancer Ther 2017; 16: 408-414 [PMID: 28151706 DOI: 10.1158/1535-7163.MCT-16-0663]
27. Heryanto YD, Hanaoka H, Nakajima T, Yamaguchi A, Tsushima Y. Applying near-infrared photoimmunotherapy to B-cell lymphoma: comparative evaluation with radioimmunotherapy in tumor xenografts. Ann Nucl Med 2017; 31: 669-677 [PMID: 28741052 DOI: 10.1007/ s12149-017-1197-9]
28. Railkar R, Krane LS, Li QQ, Sanford T, Siddiqui MR, Haines D, Vourganti S, Brancato SJ, Choyke PL, Kobayashi H, Agarwal PK. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer. Mol Cancer Ther 2017; 16: 2201-2214 [PMID: 28619755 DOI: 10.1158/1535-7163.MCT-16-0924]
29. Jin J, Krishnamachary B, Mironchik Y, Kobayashi H, Bhujwalla ZM. Phototheranostics of CD44-positive cell populations in triple negative breast cancer. Sci Rep2016; 6: 27871 [PMID: 27302409 DOI: 10.1038/srep27871]
30. Nagaya T, Nakamura Y, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H. Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody. Mol Cancer Res 2017; 15: 1153-1162 [PMID: 28588059 DOI: 10.1158/1541-7786.MCR-17-0164]
31. Shirasu N, Yamada H, Shibaguchi H, Kuroki M, Kuroki M. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy. Int J Cancer 2014; 135: 2697-2710 [PMID: 24740257 DOI: 10.1002/ ijc.28907]
32. Maawy AA, Hiroshima Y, Zhang Y, Heim R, Makings L, Garcia-Guzman M, Luiken GA, Kobayashi H, Hoffman RM, Bouvet M. Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer. PLoS One 2015; 10: e0121989 [PMID: 25799218 DOI: 10.1371/journal.pone.0121989]
33. Nagaya T, Nakamura Y, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Allen C, Kobayashi H. Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT. Mol Cancer Res 2017; 15: 1667-1677 [PMID: 28923838 DOI: 10.1158/1541-7786. MCR-17-0333]
34. Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Hodge JW, Schlom J, Kobayashi H. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody. Oncotarget 2017; 8: 8807-8817 [PMID: 27716622 DOI: 10.18632/ oncotarget.12410]
35. Nakajima T, Sano K, Choyke PL, Kobayashi H. Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model. Theranostics 2013; 3: 357-365 [PMID: 23781283 DOI: 10.7150/thno.5908]
36. Nitori N, Ino Y, Nakanishi Y, Yamada T, Honda K, Yanagihara K, Kosuge T, Kanai Y, Kitajima M, Hirohashi S. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Clin Cancer Res 2005; 11: 2531-2539 [PMID: 15814630 DOI: 10.1158/1078-0432. CCR-04-0866]
37. Vrana JA, Stang MT, Grande JP, Getz MJ. Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. Cancer Res 1996; 56: 5063-5070 [PMID: 8895765]
38. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996; 2: 209-215 [PMID: 8574967]
39. Kobayashi H, Choyke PL. Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy. Nanoscale 2016; 8: 12504-12509 [PMID: 26443992 DOI: 10.1039/c5nr05552k]
40. Sano K, Nakajima T, Choyke PL, Kobayashi H. The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapy. Mol Cancer Ther 2014; 13: 426-432 [PMID: 24356818 DOI: 10.1158/1535-7163.MCT-13-0633]
41. Sano K, Nakajima T, Choyke PL, Kobayashi H. Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. ACS Nano 2013; 7: 717-724 [PMID: 23214407 DOI: 10.1021/nn305011p]
42. Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Kobayashi H. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT). J Control Release 2016; 232: 1-8 [PMID: 27059723 DOI: 10.1016/ j.jconrel.2016.04.003]
43. Mitsunaga M, Nakajima T, Sano K, Choyke PL, Kobayashi H. Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. Bioconjug Chem 2012; 23: 604-609 [PMID: 22369484 DOI: 10.1021/bc200648m]
44. Dzurinko VL, Gurwood AS, Price JR. Intravenous and indocyanine green angiography. Optometry 2004; 75: 743-755 [PMID: 15624671]
45. Sharma R, Wendt JA, Rasmussen JC, Adams KE, Marshall MV, Sevick-Muraca EM. New horizons for imaging lymphatic function. Ann N Y Acad Sci 2008; 1131: 13-36 [PMID: 18519956 DOI: 10.1196/ annals.1413.002]
46. Shirata C, Kaneko J, Inagaki Y, Kokudo T, Sato M, Kiritani S, Akamatsu N, Arita J, Sakamoto Y, Hasegawa K, Kokudo N. Near-infrared photothermal/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress. Sci Rep 2017; 7: 13958 [PMID: 29066756 DOI: 10.1038/ s41598-017-14401-0]
47. Tseng WW, Saxton RE, Deganutti A, Liu CD. Infrared laser activation of indocyanine green inhibits growth in human pancreatic cancer. Pancreas 2003; 27: e42-e45 [PMID: 14508139]
48. Radzi R, Osaki T, Tsuka T, Imagawa T, Minami S, Nakayama Y, Okamoto Y. Photodynamic hyperthermal therapy with indocyanine green (ICG) induces apoptosis and cell cycle arrest in B16F10 murine melanoma cells. J Vet Med Sci 2012; 74: 545-551 [PMID: 22146339]
49. Reindl S, Penzkofer A, Gong SH, Landthaler M, Szeimies RM, Abels C, Baumler W. Quantum yield of triplet formation for indocyanine green. J Photoch Photobio A 1997; 105: 65-68 [DOI: 10.1016/ S1010-6030(96)04584-4]
50. Bäumler W, Abels C, Karrer S, Weiss T, Messmann H, Landthaler M, Szeimies RM. Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer 1999; 80: 360-363 [PMID: 10408838 DOI: 10.1038/sj.bjc.6690363]
51. Urbanska K, Romanowska-Dixon B, Matuszak Z, Oszajca J, Nowak-Sliwinska P, Stochel G. Indocyanine green as a prospective sensitizer for photodynamic therapy of melanomas. Acta Biochim Pol 2002; 49: 387-391 [PMID: 12362980]
52. Ogawa M, Tomita Y, Nakamura Y, Lee MJ, Lee S, Tomita S, Nagaya T, Sato K, Yamauchi T, Iwai H, Kumar A, Haystead T, Shroff H, Choyke PL, Trepel JB, Kobayashi H. Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity. Oncotarget 2017; 8: 10425-10436 [PMID: 28060726 DOI: 10.18632/oncotarget.14425]